Prospective, Multi-Center, Observational, Whole Blood Specimen Collection Study in Participants with Rheumatoid Arthritis with Inadequate Response or Intolerance to a DMARD Starting a New BDMARD or TsDMARD Treatment +/- CsDMARD
RecruitingOBSERVATIONAL
Enrollment
1,410
Participants
Timeline
Start Date
June 29, 2023
Primary Completion Date
June 30, 2025
Study Completion Date
December 31, 2025
Conditions
Rheumatoid Arthritis
Trial Locations (1)
28207
RECRUITING
Arthritis and Osteoporosis Consultants of the Carolinas, Charlotte